---
title: "Global Cord Blood Corporation (CORBF.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/CORBF.US.md"
symbol: "CORBF.US"
name: "Global Cord Blood Corporation"
industry: "Health Care Services"
---

# Global Cord Blood Corporation (CORBF.US)

| Item | Detail |
|------|--------|
| Industry | Health Care Services |
| Location | US Market |

## Company Profile

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores ...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-21T04:30:14.000Z

**Overall: C (0.43)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 49 / 86 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 12.54% |  |
| Net Profit YoY | 3.49% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.00 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 133.91M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 193.88M |  |


**Multi Score**: C

#### Profit Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 10.82% | B |
| Profit Margin | 40.30% | A |
| Gross Margin | 85.26% | A |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 12.54% | B |
| Net Profit YoY | 3.49% | C |
| Total Assets YoY | 11.65% | B |
| Net Assets YoY | 15.13% | A |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 248.12% | C |
| OCF YoY | 12.54% | B |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.15 | D |

#### Debt Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 42.76% | C |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Global Cord Blood Corporation",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "A",
      "indicators": [
        {
          "name": "ROE",
          "value": "10.82%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "40.30%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "85.26%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "12.54%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "3.49%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "11.65%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "15.13%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "248.12%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "12.54%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.15",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "C",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "42.76%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | TalkSpace (US.TALK) | C | B | A | A | A | A |
| 02 | Cigna (US.CI) | B | B | A | D | B | B |
| 03 | BrightSpring Health Services - Unit (US.BTSGU) | C | A | A | D | A | B |
| 04 | Labcorp (US.LH) | B | C | B | C | B | B |
| 05 | Quest Diagnostics (US.DGX) | B | B | B | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/CORBF.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/CORBF.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/CORBF.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.